PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea.\', \'College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea.\', \'Viroclinics Biosciences, Rotterdam, the Netherlands.\', \'National Institute for Communicable Disease, Johannesburg of the National Health Laboratory Services, South Africa.\', \'Biotechnology Research Institute, Celltrion Inc., Incheon, Republic of Korea. Electronic address: sooyoung.lee@celltrion.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0006-291X(21)00931-110.1016/j.bbrc.2021.06.016
?:hasPublicationType
?:journal
  • Biochemical and biophysical research communications
is ?:pmid of
?:pmid
?:pmid
  • 34119826
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.087
?:rankingScore_hIndex
  • 237
is ?:relation_isRelatedTo_publication of
?:title
  • Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34119826>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34119826>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all